Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99.6M
-
Number of holders
-
214
-
Total 13F shares, excl. options
-
85.1M
-
Shares change
-
+5.19M
-
Total reported value, excl. options
-
$3.68B
-
Value change
-
+$239M
-
Put/Call ratio
-
1.06
-
Number of buys
-
103
-
Number of sells
-
-112
-
Price
-
$43.30
Significant Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q1 2017
273 filings reported holding NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock as of Q1 2017.
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) has 214 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 85.1M shares
of 99.6M outstanding shares and own 85.39% of the company stock.
Largest 10 shareholders include FMR LLC (12M shares), VANGUARD GROUP INC (6.74M shares), BlackRock Inc. (5.03M shares), JANUS CAPITAL MANAGEMENT LLC (4.36M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.11M shares), PERCEPTIVE ADVISORS LLC (3.37M shares), BB BIOTECH AG (3.2M shares), FRANKLIN RESOURCES INC (2.8M shares), Invesco Ltd. (2.72M shares), and STATE STREET CORP (2.58M shares).
This table shows the top 214 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.